Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2025-12-25 @ 12:56 PM
NCT ID: NCT00618995
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00618995
Study Brief: A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Placebo once daily for 7 days None None 0 22 11 22 View
ER Niacin/Laropiprant Extended Release (ER) Niacin 2 g/Laropiprant 40 mg once daily for 7 days None None 0 23 17 23 View
ER Niacin ER Niacin 2 g once daily for 7 days None None 1 25 23 25 View
Laropiprant Laropiprant 40 mg once daily for 7 days None None 0 23 12 23 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Vomiting None Gastrointestinal disorders MedDRA (10.1) View
Acidosis None Metabolism and nutrition disorders MedDRA (10.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal Discomfort None Gastrointestinal disorders MedDRA (10.1) View
Abdominal Distension None Gastrointestinal disorders MedDRA (10.1) View
Abdominal Pain None Gastrointestinal disorders MedDRA (10.1) View
Abdominal Pain Upper None Gastrointestinal disorders MedDRA (10.1) View
Constipation None Gastrointestinal disorders MedDRA (10.1) View
Diarrhoea None Gastrointestinal disorders MedDRA (10.1) View
Dyspepsia None Gastrointestinal disorders MedDRA (10.1) View
Nausea None Gastrointestinal disorders MedDRA (10.1) View
Vomiting None Gastrointestinal disorders MedDRA (10.1) View
Asthenia None General disorders MedDRA (10.1) View
Feeling Hot None General disorders MedDRA (10.1) View
Hypoglycaemia None Metabolism and nutrition disorders MedDRA (10.1) View
Back Pain None Musculoskeletal and connective tissue disorders MedDRA (10.1) View
Burning Sensation None Nervous system disorders MedDRA (10.1) View
Dizziness None Nervous system disorders MedDRA (10.1) View
Headache None Nervous system disorders MedDRA (10.1) View
Paraesthesia None Nervous system disorders MedDRA (10.1) View
Erythema None Skin and subcutaneous tissue disorders MedDRA (10.1) View
Pruritus None Skin and subcutaneous tissue disorders MedDRA (10.1) View
Flushing None Vascular disorders MedDRA (10.1) View